BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 13, 2007
View Archived Issues
Natural toxin shows potential against prostate cancer in vitro
Read More
New agents for treating acne and alopecia reported in recent Pfizer patent
Read More
Recent patents describe novel therapeutic agents for respiratory disorders
Read More
Novel treatment option for irritable bowel syndrome disclosed by Astellas
Read More
Identification of c-Src protein kinase inhibitors as a novel class for anti-dengue virus therapy
Read More
Anti-ribosomal P antibodies may explain CNS symptoms in SLE
Read More
Aeterna Zentaris rounds up 2006 clinical progress
Read More
Formulation work required for CRD-5 following phase I/II findings
Read More
Peplin updates progress of PEP-005 Topical program
Read More
Studies show Radilex may stimulate hematopoietic stem cells
Read More
TM-30339 advanced into clinical trials for obesity
Read More
Positive data reported from phase Ib study of TASQ
Read More
Oxford BioMedica to acquire Oxxon Therapeutics
Read More
Schering-Plough to acquire Organon Biosciences
Read More
Sym-001, first recombinant polyclonal antibody to enter clinical trials
Read More
Array BioPharma reports on anticancer activity of its p38 MAPK inhibitor
Read More
Biomarker studies test AZD-0530's potential in managing bone metastasis
Read More
Cardium Therapeutics closes private placement financing
Read More
FDA updates safety information for erythropoiesis-stimulating agents
Read More
Pemetrexed combinations found highly effective against NSCLC cells
Read More
SNS-314 shows consistent and dose-dependent antitumor activity in mice
Read More
WX-671 plus 5-FU, gemcitabine or irinotecan reduce cancer metastasis and invasion
Read More
Nitoman launched in Germany
Read More
Xyrem approved in E.U. for narcolepsy with cataplexy
Read More
Approvable letter for Accretropin
Read More